Indian Phosphate Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 27, 2026

Key Highlights

The Latest Trading Price of Indian Phosphate Ltd is ₹ 52 as of 27 Mar 13:56 . The P/E Ratio of Indian Phosphate Ltd is 0 as of March 2024 .The P/E Ratio of Saroja Pharma Industries India Ltd is 0 as of March 2024 . The Market Cap of Indian Phosphate Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Saroja Pharma Industries India Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Indian Phosphate Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Indian Phosphate Ltd

Indian Phosphate Limited was incorporated on December 14, 1998 with a Certificate of Incorporation granted by the Registrar of Companies, Rajasthan, Jaipur.
Company is mainly engaged in production of Linear Alkylbenzene Sulphonic Acid LABSA 90%, popularly known as LABSA, is an anionic surfactant and it is used in formulation of all types of detergent powders, cakes, toilet cleaners and liquid detergents.
It is also engaged in manufacturing of Single Super Phosphate (SSP) Fertilizer and Granules Single Super Phosphate (GSSP) Fertilizer which is manufactured and supplied as per the standards of Fertilizer Control Order of India in powder and granulated form as well as fortified with zinc and boron.
Single Super Phosphate and Granules Single Super Phosphate as fertilizer in nature are used in agriculture industry.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Indian Phosphate Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Indian Phosphate Ltd or Saroja Pharma Industries India Ltd?

Market cap of Indian Phosphate Ltd is 130 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Indian Phosphate Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Indian Phosphate Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indian Phosphate Ltd and Saroja Pharma Industries India Ltd?

As of March 27, 2026, the Indian Phosphate Ltd stock price is INR ₹52.15. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.35.

How do dividend payouts of Indian Phosphate Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Indian Phosphate Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.